NCT03435861View on ClinicalTrials.gov

Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 8, 2018

Primary Completion Date

April 30, 2021

Study Completion Date

June 30, 2021

Conditions
Alzheimer Disease
Interventions
DRUG

VX-745

active drug capsules

DRUG

placebo

placebo capsules

Trial Locations (1)

31000

CHU Toulouse, Toulouse

All Listed Sponsors
collaborator

Fondation Plan Alzheimer

OTHER

lead

University Hospital, Toulouse

OTHER

NCT03435861 - Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease Patients | Biotech Hunter | Biotech Hunter